A Closer Look at 10 Analyst Recommendations For Axsome Therapeutics
A Closer Look at 10 Analyst Recommendations For Axsome Therapeutics
對axsome therapeutics的10位分析師推薦進行更詳細的分析
10 analysts have shared their evaluations of Axsome Therapeutics (NASDAQ:AXSM) during the recent three months, expressing a mix of bullish and bearish perspectives.
在過去的三個月中,有10位分析師分享了他們對axsome therapeutics(納斯達克: AXSM)的評價,表達了看好和看淡的不同觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照,展示了情緒在過去30天中的演變情況,並將其與之前的月份進行比較。
In the assessment of 12-month price targets, analysts unveil insights for Axsome Therapeutics, presenting an average target of $131.9, a high estimate of $180.00, and a low estimate of $107.00. This upward trend is evident, with the current average reflecting a 0.77% increase from the previous average price target of $130.89.
在對axsome therapeutics的12個月目標價格進行評估時,分析師揭示了一些見解,提出了一個平均目標爲131.9美元,一個高估值爲180.00美元,一個低估值爲107.00美元。這種上升趨勢是顯而易見的,當前平均目標反映了與上一個130.89美元平均目標相比的0.77%的增長。
Analyzing Analyst Ratings: A Detailed...
分析分析師...
登入免費觀看全文
登入/註冊